Clindamycin Pfizer, Granulat zur Herstellung einer Lösung zum Einnehmen
7680618970013
CH-61897
Granulat
Associated product:
CLINDAMYCIN Pfizer gran 75 mg/5ml fl 80 ml
1 / 3
google
Article details
- Package size
- 80
- Selling units
- 80
- Measure
- ml
- Galenic form
- Granulat
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.8 G | Substance | HBESI |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
0.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 25.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2011
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 61897
- Drug name
- Clindamycin Pfizer, Granulat zur Herstellung einer Lösung zum Einnehmen
- Galenic form
- GRAL
- ATC Code
- J01FF01
- Authorization status
- Z
- Authorization category
- Category C
- Dispensing category
- A
- First authorization
- 10/03/2011
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.01.92
- Domain
- Human medicine
Package details
- Description (FR)
- CLINDAMYCIN Pfizer gran 75 mg/5ml fl 80 ml
- Description (DE)
- CLINDAMYCIN Pfizer Gran 75 mg/5ml Fl 80 ml
- Market launch
- 10/03/2011
- Narcotic (BTM)
- No
Original drug
Dalacin C 75 mg/5 ml, Granulat zur Herstellung einer Lösung zum Einnehmen
GTIN: 7680379050115
CHF 26.15